• Users Online: 538
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2020  |  Volume : 5  |  Issue : 3  |  Page : 237-240

Use of hydroxyprogesterone caproate injection for prevention of preterm labor in women with different risk factors: a mini review

Department of Obstetrics and Gynaecology, Woman's Health Hospital, Faculty of Medicine, Assiut University, Assiut, Egypt

Correspondence Address:
Ayman H Shaamash
Department of Obstetrics and Gynaecology, Woman's Health Hospital, Assiut University, Assiut 71116
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JCMRP.JCMRP_54_19

Rights and Permissions

Preterm birth is delivery before 37 weeks of gestation it remains a global challenge with an incidence of 11.1% (1). Progestogens are the only medications that their use showed reduction in incidence of preterm birth (2.3) they are used in asymptomatic women who are at increased risk of preterm birth based on their history and ultrasound finding of short cervical length, their use is supported and guideline recommendation published by Society for Maternal Fetal Medicine publications committee 2012 ,American collage of Obstetricians and gynecology committee on practice bulletin 2012 and European Association of PerinatalMedicine.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded64    
    Comments [Add]    

Recommend this journal